TGF-β in renal injury and disease

被引:322
作者
Bottinger, Erwin P. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
关键词
fibrosis; chronic kidney disease; cell biology; signal transduction; apoptosis;
D O I
10.1016/j.semnephrol.2007.02.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic progressive kidney diseases typically are characterized by loss of differentiated epithelial cells and activation of mesenchymal cell populations leading to renal fibrosis in response to a broad range of diverse renal injuries. Recent evidence has indicated that epithelial microinjury leads to unbalanced epithelial-mesenchymal communication to initiate the fibrotic response. Transforming growth factors beta constitute a large family of cytokines that control key cellular responses in development and tissue repair. Activation of autocrine and paracrine transforming growth factor-beta signaling cascades in the context of epithelial microinjuries initiate a variety of cell type- dependent signaling and activity profiles, including epithelial apoptosis and epithelial-to-mesenchymal transition, that trigger fibrogenic foci and initiate progressive fibrogenesis in chronic renal injury.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 123 条
[1]   INTRAGLOMERULAR HYPERTENSION - IMPLICATIONS AND DRUG-TREATMENT [J].
ANDERSON, S ;
BRENNER, BM .
ANNUAL REVIEW OF MEDICINE, 1988, 39 :243-253
[2]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[3]   Transforming growth factor-beta(1) is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase [J].
Arsalane, K ;
Dubois, CM ;
Muanza, T ;
Begin, R ;
Boudreau, F ;
Asselin, C ;
Cantin, AM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) :599-607
[4]  
Bitzer M, 2000, GENE DEV, V14, P187
[5]   Transforming growth factor-β in renal disease [J].
Bitzer, M ;
Sterzel, RB ;
Böttinger, EP .
KIDNEY & BLOOD PRESSURE RESEARCH, 1998, 21 (01) :1-12
[6]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[7]   NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE [J].
BORDER, WA ;
NOBLE, NA ;
YAMAMOTO, T ;
HARPER, JR ;
YAMAGUCHI, Y ;
PIERSCHBACHER, MD ;
RUOSLAHTI, E .
NATURE, 1992, 360 (6402) :361-364
[8]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[9]   Lessons from TGF-β transgenic mice [J].
Böttinger, EP ;
Kopp, JB .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) :154-160
[10]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610